EFFECTIVENESS AND TOLERABILITY OF CV-3988, A SELECTIVE PAF ANTAGONIST, AFTER INTRAVENOUS ADMINISTRATION TO MAN

被引：28
|
作者：
ARNOUT, J
VANHECKEN, A
DELEPELEIRE, I
MIYAMOTO, Y
HOLMES, I
DESCHEPPER, P
VERMYLEN, J
机构：
[1] CATHOLIC UNIV LEUVEN,DEPT HUMAN BIOL,PHARMACOL LAB,B-3000 LOUVAIN,BELGIUM
[2] TAKEDA CHEM IND LTD,DIV NEW PROD PLANNING & DEV,OSAKA 532,JAPAN
[3] GH BESSELAAR ASSOCIATES,ZOLLIKON,SWITZERLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 25卷 / 04期
关键词：
D O I：
10.1111/j.1365-2125.1988.tb03328.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：445 / 451
页数：7
相关论文
共 50 条
  • [21] PREVENTION OF ENDOTOXIN-INDUCED GASTROINTESTINAL DAMAGE BY CV-3988, AN ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    WALLACE, JL
    WHITTLE, BJR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 124 (1-2) : 209 - 210
  • [22] EFFECT OF THE PLATELET ACTIVATING FACTOR (PAF) ANTAGONIST, CV3988 ON ACUTE-INFLAMMATION
    ISSEKUTZ, AC
    SZPEJDA, M
    RIPLEY, M
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1271 - 1271
  • [23] PAF ANTAGONIST, CV3988, INHIBITS TNF PRODUCTION BY LPS STIMULATED ALVEOLAR MACROPHAGES
    LO, C
    GARCIA, I
    MAIER, RV
    FASEB JOURNAL, 1994, 8 (04): : A137 - A137
  • [24] COMPARISON OF BN-52021, A NEW INHIBITOR OF PAF-ACETHER-INDUCED PLATELET-AGGREGATION, WITH KADSURENONE AND CV-3988
    CHIGNARD, M
    NUNEZ, D
    KORTH, R
    NOREL, X
    BRAQUET, P
    BENVENISTE, J
    PROSTAGLANDINS, 1985, 30 (04): : 701 - 701
  • [25] SELECTIVE ANTAGONISM OF PLATELET-ACTIVATING-FACTOR (PAF)-INDUCED AGGREGATION AND SECRETION IN WASHED RABBIT PLATELETS BY CV-3988, L-652731, TRIAZOLAM AND ALPRAZOLAM
    COX, CP
    WOOD, KL
    THROMBOSIS RESEARCH, 1987, 47 (03) : 249 - 257
  • [26] EFFECT OF THE PAF ANTAGONISTS, CV-3988 AND L-652,731 ON THE PULMONARY AND HEMATOLOGICAL RESPONSES TO GUINEA-PIG ANAPHYLAXIS
    DANKO, G
    SHERWOOD, JE
    GRISSOM, B
    KREUTNER, W
    CHAPMAN, RW
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1988, 20 (09): : 785 - 798
  • [27] EFFECT OF CV-3988, A SPECIFIC ANTAGONIST AGAINST PLATELET ACTIVATING FACTOR, ON HOMOLOGOUS PASSIVE CUTANEOUS ANAPHYLAXIS IN THE MOUSE EAR
    INAGAKI, N
    MIURA, T
    OHIRA, K
    NAGAI, H
    XU, Q
    KODA, A
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1990, 13 (05): : 272 - 277
  • [28] SUPPRESSION OF PHORBOL-MYRISTATE ACETATE-INDUCED PLEURISY BY CV-3988, AN ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    OHISHI, S
    YAMAKI, K
    HAYASHI, M
    TSUSHIMA, S
    NOMURA, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (11) : 4896 - 4898
  • [29] SPECIFIC-INHIBITION OF PAF-ACETHER-INDUCED PLATELET ACTIVATION BY BN-52021 AND COMPARISON WITH THE PAF-ACETHER INHIBITORS KADSURENONE AND CV-3988
    NUNEZ, D
    CHIGNARD, M
    KORTH, R
    LECOUEDIC, JP
    NOREL, X
    SPINNEWYN, B
    BRAQUET, P
    BENVENISTE, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 123 (02) : 197 - 205
  • [30] BRONCHOCONSTRICTION INDUCED BY PLATELET-ACTIVATING FACTOR IN THE GUINEA-PIG AND ITS INHIBITION BY CV-3988, A PAF ANTAGONIST - SERIAL CHANGES IN FINDINGS OF LUNG HISTOLOGY AND BRONCHOALVEOLAR LAVAGE CELL-POPULATION
    TAKIZAWA, H
    ISHII, A
    SUZUKI, S
    SHIGA, J
    MIYAMOTO, T
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1988, 86 (04): : 375 - 382
12345